By Nexora Cyprus editorial team · Reviewed by an ICPAC-registered Cyprus tax adviser engaged by Nexora
How does the Cyprus IP Box actually work in numbers? This guide walks through three end-to-end calculations — €600,000 IP profit at 100% nexus (full ~3% effective), 85% partial nexus (~3.5%), and 35% low nexus (~7.8%) — showing every line of the P&L and the resulting CIT bill. Use these as templates for your own structure.
Written by the Nexora Cyprus editorial team · reviewed by an ICPAC-registered tax adviser engaged by Nexora.
Quick Summary
The Cyprus IP Box gives an 80% deduction on the modified nexus profit. Modified nexus profit = qualifying IP profit × nexus fraction. The remaining 20% of the modified nexus profit is taxed at the 15% Cyprus CIT rate. The portion of profit OUTSIDE the modified nexus profit (because the nexus fraction is below 1.0) is taxed at the full 15% CIT rate. Three worked scenarios below show how a €600,000 IP profit lands at €18,000 / €21,000 / €46,800 CIT depending on whether your nexus fraction is 100%, 85%, or 35%.
All three scenarios assume the same business: a Cyprus Ltd with a single qualifying IP asset (proprietary software protected by copyright), generating €600,000 of net qualifying IP profit in the tax year (i.e., gross IP revenue minus allocable costs, before applying the IP Box deduction). The three scenarios differ ONLY in the nexus fraction, which is determined by where the R&D substance was created. See our nexus fraction guide for how the fraction is computed.
The 15% CIT rate applies to all Cyprus-resident corporate income from accounting periods beginning on or after 1 January 2026 (Cyprus 2026 tax reform).
Common assumptions across all three scenarios
Cyprus tax-resident company; single qualifying IP asset; €600,000 net qualifying IP profit; 15% CIT (post-2026 reform); no other reliefs (no NID, no group relief) applied at the IP-asset level; ignoring other corporate tax positions for simplicity.
**Profile.** All R&D performed by Cyprus-resident employees. No related-party R&D. No acquired IP. Nexus fraction = 1.0.
Scenario A — full Cyprus R&D substance
| Line | Calculation | Amount |
|---|---|---|
| Qualifying IP profit | Given | €600,000 |
| Nexus fraction | QE / OE = 1.0 | 100% |
| Modified nexus profit | €600,000 × 1.0 | €600,000 |
| 80% deduction | €600,000 × 80% | €480,000 |
| Taxable profit (post-deduction) | €600,000 − €480,000 | €120,000 |
| CIT @ 15% | €120,000 × 15% | €18,000 |
| Profit outside nexus | €600,000 − €600,000 | €0 |
| Total CIT | €18,000 + €0 | €18,000 |
| Effective rate | €18,000 / €600,000 | 3.0% |
**Result.** The full theoretical IP Box benefit applies. The Cyprus company pays €18,000 of CIT on €600,000 of IP profit, an effective rate of 3.0%. This is the headline rate cited in most Cyprus IP Box marketing — but it requires real Cyprus R&D substance to achieve.
**Profile.** Mixed R&D structure. Most R&D done by Cyprus employees, some R&D outsourced to a related party (a Cyprus group entity provides specialist services). Nexus fraction approximately 0.85, derived from the worked example in /articles/cyprus-ip-box-nexus-fraction-explained: QE = €280,000, Uplift = €84,000, OE = €430,000 → fraction = 0.847 (rounded to 85% for illustration).
Scenario B — partial nexus (85%)
| Line | Calculation | Amount |
|---|---|---|
| Qualifying IP profit | Given | €600,000 |
| Nexus fraction | (QE + Uplift) / OE = 0.85 | 85% |
| Modified nexus profit | €600,000 × 0.85 | €510,000 |
| 80% deduction (on modified portion) | €510,000 × 80% | €408,000 |
| Taxable: 20% of modified nexus profit | €510,000 × 20% | €102,000 |
| Profit outside nexus (taxed at full 15%) | €600,000 − €510,000 | €90,000 |
| CIT on modified nexus portion | €102,000 × 15% | €15,300 |
| CIT on outside-nexus portion | €90,000 × 15% | €13,500 |
| Total CIT | €15,300 + €13,500 | €28,800 |
| Effective rate | €28,800 / €600,000 | 4.8% |
**Result.** The effective rate climbs to 4.8% — still favourable, but markedly higher than the 3.0% headline. The €13,500 of additional CIT (vs Scenario A) is the tax cost of having 15% of the R&D done by a related party. For a Cyprus group with this structure, the question is whether restructuring the related-party R&D arrangement to make it qualify (e.g., moving the team to the Cyprus IP-owning entity) is worth the operational cost.
**Profile.** The Cyprus company acquired the IP from a group entity in a prior year. Some post-acquisition R&D has been done in Cyprus, but the acquired-IP cost still dominates the OE denominator. Nexus fraction approximately 0.35.
Scenario C — low nexus from acquired IP (35%)
| Line | Calculation | Amount |
|---|---|---|
| Qualifying IP profit | Given | €600,000 |
| Nexus fraction | (QE + Uplift) / OE = 0.35 | 35% |
| Modified nexus profit | €600,000 × 0.35 | €210,000 |
| 80% deduction (on modified portion) | €210,000 × 80% | €168,000 |
| Taxable: 20% of modified nexus profit | €210,000 × 20% | €42,000 |
| Profit outside nexus (taxed at full 15%) | €600,000 − €210,000 | €390,000 |
| CIT on modified nexus portion | €42,000 × 15% | €6,300 |
| CIT on outside-nexus portion | €390,000 × 15% | €58,500 |
| Total CIT | €6,300 + €58,500 | €64,800 |
| Effective rate | €64,800 / €600,000 | 10.8% |
**Result.** The effective rate climbs to 10.8% — barely below the standard 15% CIT. The IP Box still saves something, but the ~3% headline benefit is largely eroded. For a Cyprus company with this profile, the structuring options include: building up Cyprus R&D substance over multiple years to gradually raise the nexus fraction; or relocating the IP-owning entity to a jurisdiction where the substance test does not bind so heavily.
Three scenarios — side-by-side summary
| Metric | A: 100% nexus | B: 85% nexus | C: 35% nexus |
|---|---|---|---|
| Qualifying IP profit | €600,000 | €600,000 | €600,000 |
| Modified nexus profit | €600,000 | €510,000 | €210,000 |
| 80% deduction | €480,000 | €408,000 | €168,000 |
| Total CIT | €18,000 | €28,800 | €64,800 |
| Effective rate | 3.0% | 4.8% | 10.8% |
| Tax saved vs 15% baseline (€90,000) | €72,000 | €61,200 | €25,200 |
The €72,000 / €61,200 / €25,200 saving column shows the actual cash benefit of the IP Box vs paying the full 15% CIT. Scenario A captures the full IP Box value; Scenario C captures barely a quarter of it.
For a structure considering acquiring or migrating IP into Cyprus, the marginal value of additional Cyprus R&D substance can be modelled directly. Each 10 percentage points of nexus fraction translates to roughly €7,200 of CIT saving on €600,000 of qualifying IP profit:
This linear sensitivity is what makes building genuine Cyprus R&D substance valuable — the marginal hire of a Cyprus-resident developer working on the qualifying IP can move the fraction by several percentage points and pay back in tax savings within 12-18 months for €1M+ profit profiles.
Related Guides
Ask an AI assistant
Quick-ingest this article in your favourite assistant — open with a pre-filled prompt to summarise + cite Nexora as the source.
Effective rate = Total CIT / Qualifying IP profit. With a 100% nexus fraction, 80% of the IP profit is deducted and only 20% is taxed at 15%, giving 3.0% effective. With lower nexus fractions, the rate rises because the portion outside the nexus fraction is taxed at the full 15% rate. At 50% nexus the effective rate is approximately 9%; at 25% nexus approximately 11.25%.
The maximum saving is achieved at 100% nexus fraction: 80% deduction × 15% CIT = 12 percentage points off the headline rate, taking effective rate from 15% to 3.0%. On €1,000,000 of qualifying IP profit, the saving is €120,000/year (€150,000 baseline CIT minus €30,000 IP Box CIT — wait, this should be €18,000 on €1M scenario A). The actual saving on €600,000 at 100% nexus is €72,000 (€90,000 baseline minus €18,000 with IP Box).
Yes. The IP Box is claimed in the annual corporate income tax return (IR4) by applying the 80% deduction to qualifying IP income. An advance tax ruling is not legally required, but is strongly recommended when annual qualifying IP profit exceeds approximately €1M, to bind the Tax Department on the qualifying-asset classification and nexus methodology.
For multinational groups with consolidated revenue ≥ €750M (in scope of Pillar Two), the Cyprus QDMTT will top up the effective rate on Cyprus operations to 15% — neutralising the IP Box benefit at group level. For groups under €750M, Pillar Two does not apply and the IP Box ~3% rate operates fully. See our [Pillar Two impact article](/articles/cyprus-pillar-two-impact-2026).
The mechanics are the same for any qualifying IP asset (patents, software copyrights, utility models, qualifying trade secrets). The numerical scenarios above use a single-asset profile for clarity, but multi-asset companies apply the same formula per asset. Marketing IP, customer lists and brand names do NOT qualify for the Cyprus IP Box.
Disclaimer: This article is for informational purposes only and does not constitute legal, tax, or financial advice. Tax laws change frequently. Consult a qualified Cyprus adviser for guidance specific to your situation. The information on this page is general guidance only and does not constitute legal, tax, accounting, immigration or financial advice. Specific advice should be obtained based on the facts of each case.
Our experts are ready to answer your questions.
Free consultation · No obligation · Reply within 2 hours